Huadong Medicine Co (SZSE:000963) Ending Cash Position : ¥3,105 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Ending Cash Position?

Huadong Medicine Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥3,105 Mil.

Huadong Medicine Co's quarterly Ending Cash Position increased from Sep. 2023 (¥3,479 Mil) to Dec. 2023 (¥4,208 Mil) but then declined from Dec. 2023 (¥4,208 Mil) to Mar. 2024 (¥3,105 Mil).

Huadong Medicine Co's annual Ending Cash Position declined from Dec. 2021 (¥3,580 Mil) to Dec. 2022 (¥3,417 Mil) but then increased from Dec. 2022 (¥3,417 Mil) to Dec. 2023 (¥4,208 Mil).

Huadong Medicine Co Ending Cash Position Historical Data

The historical data trend for Huadong Medicine Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Ending Cash Position Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,231.77

3,157.41

3,580.14

3,416.91

4,208.16

Huadong Medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,885.82	3,943.43	3,479.47	4,208.16	3,105.15

Huadong Medicine Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Huadong Medicine Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3416.91	+	791.25
	=	4,208

Huadong Medicine Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4208.161	+	-1103.011
	=	3,105

Huadong Medicine Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines